Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myotubularin-related protein 9 like, pseudogene (MTMR9LP) is annotated as a pseudogene in the human genome. Pseudogenes do not encode functional proteins and are generally regarded as non-coding genetic elements derived from duplication or retrotransposition events. MTMR9LP has no evidence of encoding a protein or having a recognized biological function. It is listed in gene databases such as HGNC and GeneCards as a pseudogene, and no known therapeutic, biochemical, or disease relevance has been established for this locus[5]. There are no reports implicating MTMR9LP as a therapeutic target, receptor, enzyme, or other molecule with pharmacological interest. No interacting drugs, mechanisms of action, biomarkers, or safety concerns associated with this pseudogene have been described in the scientific literature or biomedical databases[5]. Pseudogenes in general can sometimes modulate gene expression through non-coding RNA mechanisms, but no such role is documented for MTMR9LP specifically[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myotubularin-related protein 9 like, pseudogene (MTMR9LP).